From virus to immune system: Harnessing membrane‐derived vesicles to fight COVID‐19 by interacting with biological molecules
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350916 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Jiayuan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory & Center for Molecular Imaging and Translational Medi…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, COVID-19 Drug Treatment. Die Arbeit nennt 86 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Major State Basic Research Development Program of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Emerging and re‐emerging viral pandemics have emerged as a major public health concern. Highly pathogenic coronaviruses, which cause severe respiratory disease, threaten human health and socioeconomic development. Great efforts are being devoted to the development of safe and efficacious therapeutic agents and preventive vaccines to combat them. Nevertheless, the highly mutated virus poses a challenge to drug development and vaccine efficacy, and the use of common immunomodulatory agents lacks specificity. Benefiting from the burgeoning intersection of biological engineering and biotechnology, membrane‐derived vesicles have shown superior potential as therapeutics due to their biocompatibility, design flexibility, remarkable bionics, and inherent interaction with phagocytes. The interactions between membrane‐derived vesicles, viruses, and the immune system have emerged as a new and promising topic. This review provides insight into considerations for developing innovative antiviral strategies and vaccines against SARS‐CoV‐2. First, membrane‐derived vesicles may provide potential biomimetic decoys with a high affinity for viruses to block virus‐receptor interactions for early interruption of infection. Second, membrane‐derived vesicles could help achieve a balanced interplay between the virus and the host's innate immunity. Finally, membrane‐derived vesicles have revealed numerous possibilities for their employment as vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China.
- Clinical Center for Biotherapy, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Shen Zhen Research Institute of Xiamen University, Xiamen University, Shenzhen, China.
Förderung
- National Natural Science Foundation of China
- Major State Basic Research Development Program of China
- Fundamental Research Funds for the Central Universities
- Program for New Century Excellent Talents in University, China
- Shenzhen Science and Technology Program
Zitieren
APA
Li, J., Xiao, H., Zhang, C., Liu, G., & Liu, X. (2024). From virus to immune system: Harnessing membrane‐derived vesicles to fight COVID‐19 by interacting with biological molecules. European Journal of Immunology. https://doi.org/10.1002/eji.202350916
Vancouver
Li J, Xiao H, Zhang C, Liu G, Liu X. From virus to immune system: Harnessing membrane‐derived vesicles to fight COVID‐19 by interacting with biological molecules. European Journal of Immunology. 2024. doi:10.1002/eji.202350916
BibTeX
@article{Li2024,
author = {Li, Jiayuan and Xiao, Haiqing and Zhang, Chang and Liu, Gang and Liu, Xuan},
title = {From virus to immune system: Harnessing membrane‐derived vesicles to fight COVID‐19 by interacting with biological molecules},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350916}
}
EUVIMED